How many FDA warning letters has SCIEGEN PHARMS received?

Argus HQ has not recorded an FDA warning letter for SCIEGEN PHARMS in our current dataset.

What FDA recalls has SCIEGEN PHARMS issued?

Argus HQ has not recorded an FDA recall tied to SCIEGEN PHARMS in our current dataset.

Is SCIEGEN PHARMS FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 2 approval records for SCIEGEN PHARMS. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

SCIEGEN PHARMS

Name: FDA Enforcement Actions Against SCIEGEN PHARMS
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-07-01
SCIEGEN PHARMS — ANDA approval: BRIVARACETAM (unspecified)
fda_approval · anda2026-06-25
SCIEGEN PHARMS — ANDA approval: TOFACITINIB CITRATE (unspecified)

Frequently asked questions

How many FDA warning letters has SCIEGEN PHARMS received?: Argus HQ has not recorded an FDA warning letter for SCIEGEN PHARMS in our current dataset.
What FDA recalls has SCIEGEN PHARMS issued?: Argus HQ has not recorded an FDA recall tied to SCIEGEN PHARMS in our current dataset.
Is SCIEGEN PHARMS FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 2 approval records for SCIEGEN PHARMS. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.